Quester Venture Partnership（一）.pdfVIP

Quester Venture Partnership News release XX April 2002 Quester Announces Strong Support for New Institutional Venture Capital Fund Quester, a leading UK venture capital firm specialising in early development stage investment, is pleased to announce over €115 million of commitments for its new institutional venture capital fund, Quester Venture Partnership (“QVP”). Quester has secured commitments from prominent institutions from the UK, Europe, North America and Japan. QVP is only open for investment to professional investors. “We are very pleased with this response to QVP, especially given the recent difficult market conditions for raising funds of this type,” says Quester managing director Andrew Holmes. Since it was founded in 1984, Quester has established a reputation as a value-added source of finance for young and growing technology companies. Given its strong deal flow and active involvement with portfolio companies the group is aiming to deliver attractive returns for its limited partners. With a focused investment strategy, QVP will aim to invest 80% in Information and Communication Technologies (“ICT”) and 20% in Healthcare and Life Sciences, creating a balanced portfolio of about 30 companies. Since 1990, Quester has invested in 86 companies. Investments include SurfControl, First Fibre, Aethos, Danionics, C-Dilla, Comino, Biotrace and Epic Group. Given Quester’s strength of working in close collaboration with management to provide a significant strategic contribution, the group continues to receive numerous referrals from entrepreneurs they have backed before. In addition, the group as a result of its growing range of university relationships including Oxford, Bristol, Bath and Southampton, has a good insight into emerging technologies and is likely to have access to exciting early stage investment opportunities. The investment team has already completed six investments for QVP totalling £[] mill